EP2491926
Treatment of protein degradation disorders
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.3.2006EP published:
9.5.2018EP application number:
12150229.8
EPO information:
European Patent Register
Max expiry date:
21.3.2026
Title:
Treatment of protein degradation disorders
Timeline
Today
22.3.2006EP application
9.5.2018EP Publication
Owner
Name:
President and Fellows of Harvard CollegeAddress:
17 Quincy Street, 02138, Cambridge, MA, US
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Inventor
Name:
Anderson, Kenneth, C.Address:
WELLESLEY, MA Massachusetts, US
Name:
Bradner, James, ElliottAddress:
CAMBRIDGE, MA Massachusetts, US
Name:
Greenberg, Edward, FranklinAddress:
NEWTON, MA Massachusetts, US
Name:
Hideshima, TeruAddress:
BROOKLINE, MA Massachusetts, US
Name:
Kwiatkowski, Nicholas, PaulAddress:
AUBURN, MA Massachusetts, US
Name:
Mazitschek, RalphAddress:
ARLINGTON, MA Massachusetts, US
Name:
Schreiber, Stuart, L.Address:
BOSTON, MA Massachusetts, US
Name:
Shaw, JaredAddress:
CAMBRIDGE, MA Massachusetts, US
Name:
Haggarty, Stephen, JAddress:
BOSTON, MA Massachusetts, US
Priority
Number:
664470 PDate:
22.3.2005Country:
US
Classification
Categories:
A61K 31/357, A61K 31/42, A61K 31/335, A61K 31/4965, A61K 45/06, A61K 31/35, A61K 31/39, A61K 31/69, A61K 38/55, A61K 49/00, G01N 33/50, A61K 38/50, A61K 31/422, A61K 38/05